Free Trial

Neuberger Berman Group LLC Has $2.85 Million Stock Position in Neogen Corporation $NEOG

Neogen logo with Medical background

Key Points

  • Neuberger Berman Group LLC increased its stake in Neogen Corporation by 1,812.1%, acquiring 328,876 shares worth approximately $2.85 million.
  • Neogen's stock decreased 0.7% recently, currently priced at $5.50, with a 12-month high of $17.95 and a low of $3.87.
  • Wall Street analysts have reduced price targets for Neogen, with Guggenheim lowering it from $13.00 to $10.00 and Piper Sandler setting it at $5.00.
  • Want stock alerts on Neogen? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Neuberger Berman Group LLC boosted its holdings in shares of Neogen Corporation (NASDAQ:NEOG - Free Report) by 1,812.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 328,876 shares of the company's stock after purchasing an additional 311,676 shares during the quarter. Neuberger Berman Group LLC owned approximately 0.15% of Neogen worth $2,851,000 at the end of the most recent reporting period.

A number of other large investors also recently added to or reduced their stakes in the stock. Versant Capital Management Inc increased its position in shares of Neogen by 1,495.4% during the first quarter. Versant Capital Management Inc now owns 3,127 shares of the company's stock valued at $27,000 after acquiring an additional 2,931 shares during the last quarter. Johnson Financial Group Inc. purchased a new stake in Neogen in the 4th quarter valued at $43,000. Caitong International Asset Management Co. Ltd boosted its stake in shares of Neogen by 388.6% during the first quarter. Caitong International Asset Management Co. Ltd now owns 10,071 shares of the company's stock worth $87,000 after buying an additional 8,010 shares during the period. Lindenwold Advisors INC purchased a new position in shares of Neogen during the first quarter worth about $92,000. Finally, Angeles Wealth Management LLC purchased a new stake in shares of Neogen during the first quarter worth approximately $99,000. 96.73% of the stock is currently owned by institutional investors and hedge funds.

Neogen Stock Up 2.0%

NEOG stock traded up $0.11 during mid-day trading on Monday, hitting $5.54. 10,494,249 shares of the company were exchanged, compared to its average volume of 5,363,010. The company has a market capitalization of $1.20 billion, a PE ratio of -1.10 and a beta of 1.79. Neogen Corporation has a twelve month low of $3.87 and a twelve month high of $17.95. The firm has a fifty day simple moving average of $5.12 and a 200 day simple moving average of $6.76. The company has a current ratio of 3.32, a quick ratio of 2.22 and a debt-to-equity ratio of 0.42.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Piper Sandler decreased their target price on shares of Neogen from $6.40 to $5.00 and set a "neutral" rating on the stock in a research report on Tuesday, April 22nd. Guggenheim reduced their price objective on shares of Neogen from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Monday, June 30th. Finally, William Blair cut Neogen from an "outperform" rating to a "market perform" rating in a report on Tuesday, July 29th.

Get Our Latest Stock Analysis on Neogen

Neogen Company Profile

(Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

Further Reading

Institutional Ownership by Quarter for Neogen (NASDAQ:NEOG)

Should You Invest $1,000 in Neogen Right Now?

Before you consider Neogen, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list.

While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines